No Data
HK stocks unusual movement: junshi bio (01877) is currently down by over 4%, with a net loss of 0.927 billion yuan in the first three quarters. Shareholders have recently collectively reduced their shareholding by over 1%.
junshi bio (01877) is now down more than 4%, as of the time of publication, down 4.2%, at 13.24 Hong Kong dollars, with a turnover of 11.964 million Hong Kong dollars.
Shareholders in Shanghai Junshi Biosciences (HKG:1877) Have Lost 65%, as Stock Drops 4.2% This Past Week
junshi bio announced that shanghai Tan Ying and its concerted action persons collectively reduced their shareholding by more than 1% of the company's equity.
junshi bio (01877) announced that from August 24, 2023 to October 8, 2024, LVC Renaissance Fund, LVC Fund I, and LVC Fund II reduced their H shares due to fund duration and liquidity arrangements, totaling approximately 8.241 million H shares. On September 25, 2024, the company disclosed the Announcement of Shanghai junshi bio biomedical technology limited regarding shareholders holding more than 5% of the shares reducing the shareholding plan (announcement number: temporary)
Junshi Biotech Report for the Third Quarter of 2024
junshi bio (688180.SH): net loss of 0.927 billion yuan in the first three quarters.
Jinshi Biology (688180.SH) announced on October 29th that the revenue for the first three quarters of 2024 was 1.271 billion yuan, an increase of 28.87% year-on-year; net loss was 0.927 billion yuan. The revenue for the third quarter was 0.485 billion yuan, a 53.16% year-on-year increase; net loss was 0.282 billion yuan. Compared with the same period last year, the company's commercial pharmaceutical sales revenue increased, while the reduction in losses was due to multiple clinical trials of the company's core products reaching major research endpoints and other factors.
junshi bio (01877): Shanghai Tan Ying and its concerted action person together reduced their shareholding by more than 1% of the company's equity.
junshi bio (01877) announced, from August 24, 2023 to October 24, 2024 ...
Further Weakness as Shanghai Junshi Biosciences (HKG:1877) Drops 3.2% This Week, Taking Three-year Losses to 83%No Data
No Data
